Moderna, Inc. (LON: 0A45)
London
· Delayed Price · Currency is GBP · Price in USD
40.19
-1.70 (-4.06%)
At close: Jan 31, 2025
Moderna Revenue
Moderna had revenue of $1.86B USD in the quarter ending September 30, 2024, with 1.69% growth. This brings the company's revenue in the last twelve months to $5.08B, down -44.29% year-over-year. In the year 2023, Moderna had annual revenue of $6.85B, down -64.45%.
Revenue (ttm)
$5.08B
Revenue Growth
-44.29%
P/S Ratio
n/a
Revenue / Employee
$907.32K
Employees
5,600
Market Cap
12.20B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |